GlycoDesign Overview

  • Year Founded
  • 1993

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

GlycoDesign General Information

Description

Manufacturer of biopharmaceutical products intended to treat thrombosis, inflammation, and cancer using glycobiology. The company offers proprietary drug candidates and a scientific methodology for engineering carbohydrate structures, enabling the biotechnology and pharmaceutical industries to improve the efficacy and safety of therapeutic proteins.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 400-480 University Avenue
  • Toronto, Ontario M5G 1V2
  • Canada
+1 (416)
Primary Industry
Drug Discovery
Other Industries
Therapeutic Devices
Acquirer
EACOM Timber
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 400-480 University Avenue
  • Toronto, Ontario M5G 1V2
  • Canada
+1 (416)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GlycoDesign Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 05-Jun-2003 Completed Clinical Trials - Phase 2
3. IPO 30-Nov-2000 Completed Clinical Trials - Phase 2
2. Early Stage VC 06-May-1998 $16.4M $16.4M Completed Product Development
1. Early Stage VC Completed
To view GlycoDesign’s complete valuation and funding history, request access »

GlycoDesign Former Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
BDC Capital Growth/Expansion Minority
BMO Financial Group Corporation Minority
Domain Associates Venture Capital Minority
GrowthWorks Venture Capital Minority
Lumira Ventures Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

GlycoDesign Acquisitions (1)

GlycoDesign’s most recent deal was a Merger/Acquisition with Vascular Therapeutics for . The deal was made on 11-Aug-1999.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Vascular Therapeutics 11-Aug-1999 Merger/Acquisition Drug Discovery
To view GlycoDesign’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

GlycoDesign FAQs

  • When was GlycoDesign founded?

    GlycoDesign was founded in 1993.

  • Where is GlycoDesign headquartered?

    GlycoDesign is headquartered in Toronto, Canada.

  • What industry is GlycoDesign in?

    GlycoDesign’s primary industry is Drug Discovery.

  • Is GlycoDesign a private or public company?

    GlycoDesign is a Private company.

  • What is GlycoDesign’s current revenue?

    The current revenue for GlycoDesign is .

  • How much funding has GlycoDesign raised over time?

    GlycoDesign has raised $32.6M.

  • Who are GlycoDesign’s investors?

    BDC Capital, BMO Financial Group, Domain Associates, GrowthWorks, and Lumira Ventures are 5 of 8 investors who have invested in GlycoDesign.

  • When was GlycoDesign acquired?

    GlycoDesign was acquired on 05-Jun-2003.

  • Who acquired GlycoDesign?

    GlycoDesign was acquired by EACOM Timber.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process